Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Yield10 Bioscience
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of technologies to produce improvements in fuel and food crops

Founded in 2015
Founded in

Company type Public Public (YTEN)
Company type

Industry Group agriculture & food

Sector biomass & biofuels

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Woburn, MA Woburn, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Jonathan Koch at on 02/02/2018

Edited by Cleantech Group on 11/14/2024

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
01/11/2023
Mitsubishi Corporation Mitsubishi Corporation
Yield10 Bioscience and Mitsubishi Corporation Sign MOU to Evaluate the Establishment of a Partnership to Supply, Offtake and Market Camelina as a Feedstock Oil for Biofuel
View source    
Confirmed by Mitsubishi Corporation
Development Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

12/21/2017

IPO status

Listed

IPO Type

IPO

Amount

$14.5M

Initial shares

Ticker symbol

YTEN

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Yield10 Bioscience, Inc. (YTEN) announced the closing of an underwritten public offering of units for gross proceeds of $14.5 million, which includes the full exercise of the underwriter's over-allotment option to purchase additional shares and warrants, prior to deducting underwriting discounts and commissions and offering expenses payable by Yield10 Bioscience. Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc. (NYSE MKT:LTS), is sole book-running manager in connection with the offering.

Cancel Save
Add Investment
Date Investors Type Amount
02/01/2021 (0)
Post-money valuation of
underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share. The gross proceeds from the public offering will be approximately $12.7 million, the maximum amount currently available to it under the company’s shelf registration statement, before deducting underwriting discounts and commissions and estimated offering expenses.
 PIPE $12,700,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font